AdaptHealth (AHCO) – Research Analysts’ Weekly Ratings Updates

AdaptHealth (NASDAQ: AHCO) recently received a number of ratings updates from brokerages and research firms:

• 2/27/2025 – AdaptHealth had its price target raised by analysts at Robert W. Baird from $14.00 to $16.00. They now have an “outperform” rating on the stock.
• 2/26/2025 – AdaptHealth had its price target raised by analysts at Royal Bank of Canada from $11.00 to $14.00. They now have an “outperform” rating on the stock.
• 2/26/2025 – AdaptHealth had its price target raised by analysts at Canaccord Genuity Group Inc. from $13.00 to $14.00. They now have a “buy” rating on the stock.
• 2/26/2025 – AdaptHealth had its price target raised by analysts at Truist Financial Co. from $12.00 to $14.00. They now have a “buy” rating on the stock.
• 2/13/2025 – AdaptHealth had its price target lowered by analysts at UBS Group AG from $12.00 to $11.00. They now have a “buy” rating on the stock.

AdaptHealth Trading Down 5.8 %

NASDAQ:AHCO traded down $0.59 during midday trading on Wednesday, reaching $9.53. 2,036,285 shares of the stock traded hands, compared to its average volume of 1,117,677. The company has a fifty day moving average of $10.02 and a 200 day moving average of $10.25. The stock has a market capitalization of $1.29 billion, a P/E ratio of -5.78, a PEG ratio of 1.08 and a beta of 1.30. The company has a debt-to-equity ratio of 1.34, a quick ratio of 1.00 and a current ratio of 1.24. AdaptHealth Corp. has a 12 month low of $8.35 and a 12 month high of $11.90.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently made changes to their positions in the company. Pacer Advisors Inc. purchased a new position in AdaptHealth during the 4th quarter valued at about $76,271,000. Principal Financial Group Inc. lifted its holdings in shares of AdaptHealth by 204.0% during the fourth quarter. Principal Financial Group Inc. now owns 1,652,765 shares of the company’s stock valued at $15,735,000 after purchasing an additional 1,109,021 shares during the last quarter. Segall Bryant & Hamill LLC boosted its position in shares of AdaptHealth by 29.8% in the 4th quarter. Segall Bryant & Hamill LLC now owns 4,803,981 shares of the company’s stock worth $45,734,000 after purchasing an additional 1,102,173 shares in the last quarter. State Street Corp grew its stake in shares of AdaptHealth by 19.8% in the 3rd quarter. State Street Corp now owns 4,124,284 shares of the company’s stock worth $46,316,000 after buying an additional 681,816 shares during the last quarter. Finally, FMR LLC raised its stake in AdaptHealth by 9.3% during the third quarter. FMR LLC now owns 7,350,549 shares of the company’s stock valued at $82,547,000 after buying an additional 624,645 shares during the last quarter. Hedge funds and other institutional investors own 82.67% of the company’s stock.

AdaptHealth Corp., together with its subsidiaries, sells home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs.